Quarterly report · Q1
4886.TEDINET S100RJLW
Period2023-04-01 → 2023-06-30
Filed2023-08-07
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥16.0bn | 2023-04-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥60.5bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥15.3bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Operating income | ¥1.7bn | 2023-04-01 → 2023-06-30 | Cons. | Operating income |
| Operating income | ¥1.7bn | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | ¥1.8bn | 2023-04-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥5.2bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.8bn | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.9bn | 2023-04-01 → 2023-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.8bn | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.4bn | 2023-04-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥4.2bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.3bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.4bn | 2023-04-01 → 2023-06-30 | Cons. | Profit loss |
| Net income | ¥1.3bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥89.2bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥87.1bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥84.8bn | at 2022-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥32.3bn | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥32.6bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥56.9bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥54.5bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥50.5bn | at 2022-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥15.2bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥14.5bn | at 2023-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥50.51 | 2023-04-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥150.08 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥46.94 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 63.8% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.6% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 59.6% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 34
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-06-30 | ¥55m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-06-30 | ¥42m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥13m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-06-30 | −¥27m |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-06-30 | −¥13m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-06-30 | −¥13m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-06-30 | −¥288m |
| jpcrp040300-q1r_E35791-000Animal Health Businessreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥1.6bn |
| jpcrp040300-q1r_E35791-000Animal Health Businessreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥1.6bn |
| jpcrp040300-q1r_E35791-000Animal Health Businessreportable segment | segment profit | 2023-04-01 → 2023-06-30 | −¥1m |
| jpcrp040300-q1r_E35791-000Pharmaceutical Businessreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥14.4bn |
| jpcrp040300-q1r_E35791-000Pharmaceutical Businessreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥14.4bn |
| jpcrp040300-q1r_E35791-000Pharmaceutical Businessreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-06-30 | ¥16.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-06-30 | ¥16.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥13m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-06-30 | ¥2.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-06-30 | ¥44m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-06-30 | ¥29m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥15m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-06-30 | −¥18m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥15m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥15m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥169m |
| jpcrp040300-q1r_E35791-000Animal Health Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥1.6bn |
| jpcrp040300-q1r_E35791-000Animal Health Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥1.6bn |
| jpcrp040300-q1r_E35791-000Animal Health Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥124m |
| jpcrp040300-q1r_E35791-000Pharmaceutical Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥13.6bn |
| jpcrp040300-q1r_E35791-000Pharmaceutical Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥13.6bn |
| jpcrp040300-q1r_E35791-000Pharmaceutical Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥1.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-06-30 | ¥15.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-06-30 | ¥15.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥15m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-06-30 | ¥1.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 323
| Item | Context | Value | Unit |
|---|---|---|---|
| Expenses of inactive non current assets noe | Prior1YTDDuration | 13000000 | JPY |
| Expenses of inactive non current assets noe | CurrentYTDDuration | 35000000 | JPY |
| Other noe | Prior1YTDDuration | 44000000 | JPY |
| Other noe | CurrentYTDDuration | 46000000 | JPY |
| Non operating expenses | Prior1YTDDuration | 71000000 | JPY |
| Non operating expenses | CurrentYTDDuration | 93000000 | JPY |
| Ordinary income | Prior1YTDDuration | 1805000000 | JPY |
| Ordinary income | CurrentYTDDuration | 1809000000 | JPY |
| Gain on sales of investment securities ei | Prior1YTDDuration | － | JPY |
| Gain on sales of investment securities ei | CurrentYTDDuration | 64000000 | JPY |
| Extraordinary income | Prior1YTDDuration | － | JPY |
| Extraordinary income | CurrentYTDDuration | 64000000 | JPY |
| Income before income taxes | Prior1YTDDuration | 1805000000 | JPY |
| Income before income taxes | CurrentYTDDuration | 1873000000 | JPY |
| Income taxes current | Prior1YTDDuration | 199000000 | JPY |
| Income taxes current | CurrentYTDDuration | 346000000 | JPY |
| Income taxes deferred | Prior1YTDDuration | 283000000 | JPY |
| Income taxes deferred | CurrentYTDDuration | 98000000 | JPY |
| Income taxes | Prior1YTDDuration | 482000000 | JPY |
| Income taxes | CurrentYTDDuration | 444000000 | JPY |
| Profit loss | Prior1YTDDuration | 1323000000 | JPY |
| Profit loss | CurrentYTDDuration | 1428000000 | JPY |
| Profit loss attributable to owners of parent | Prior1YTDDuration | 1323000000 | JPY |
| Profit loss attributable to owners of parent | CurrentYTDDuration | 1428000000 | JPY |
| Profit loss | Prior1YTDDuration | 1323000000 | JPY |
| Profit loss | CurrentYTDDuration | 1428000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1YTDDuration | 323000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | CurrentYTDDuration | 1076000000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | Prior1YTDDuration | 6000000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | CurrentYTDDuration | -7000000 | JPY |
| Share of other comprehensive income of associates accounted for using equity method oci | Prior1YTDDuration | 139000000 | JPY |
| Share of other comprehensive income of associates accounted for using equity method oci | CurrentYTDDuration | 66000000 | JPY |
| Other comprehensive income | Prior1YTDDuration | 469000000 | JPY |
| Other comprehensive income | CurrentYTDDuration | 1135000000 | JPY |
| Comprehensive income | Prior1YTDDuration | 1792000000 | JPY |
| Comprehensive income | CurrentYTDDuration | 2563000000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 1792000000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 2563000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E35791-000PharmaceuticalBusinessReportableSegmentsMember | 13646000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E35791-000AnimalHealthBusinessReportableSegmentsMember | 1593000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 29000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 15269000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 15269000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E35791-000PharmaceuticalBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E35791-000AnimalHealthBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 15000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 15000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -15000000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |